Thank you, Dick, and good morning everyone. I am starting on Slide 5. First quarter revenue was $132.8 million, down 9% year-over-year due to the anticipated demand softness in the vehicle and industrial markets, compounded by an unfavorable $1.8 million FX impact. On a sequential basis, revenue decreased $10.8 million or 9%, reflecting solid execution and improving momentum in targeted areas like power quality and defense programs. Sales to U.S. customers represented 52% of revenue, compared with 58% in Q1 last year, with continued contributions from Europe, Canada, and Asia Pacific. Looking down our results further, let's take a closer look at how each of our key market sectors performed year-over-year. Aerospace and defense saw a 25% increase, reflecting timing of key defense and space program deliverables. We are actively pursuing several promising opportunities in the defense sector, which we anticipate will contribute to continued growth in the future. Medical remained steady, with strength in surgical equipment and tools and mobility solutions. Industrial markets were mixed, with our power quality solutions for HVAC and data center infrastructure generating solid growth. However, our total industrial market sales were down largely due to reduced demand in industrial automation. Vehicle revenue declined 34%, in line with expectations, reflecting both continued softness in power sports demand and our intentional shift from lower-margin programs as we focus on higher value, managing enhancing applications aligned with our long-term strategy. Let's move to Slide 6 for the composition of our revenue over the trailing 12 months, along with the key catalysts driving these changes. The industrial sector is our largest market, contributing 47% of the trailing 12-month sales. This market was primarily driven by strong demand for power quality solutions, as well as growth in material handling and semiconductor equipment. Industrial automation sales slowed significantly over the past year, as inventory levels and new projects have reset across the industry. Similar to the quarter, vehicle demand remained under pressure, particularly due to shifting recreational spend trends in power sports. While we saw stronger sales in surgical-related products, our medical market was down 2% on a trailing 12-month basis due to softness in pump-related products. The aerospace and defense growth reflects variability driven by contract award and government budget cycles combined with long lead times. Finally, our distributor channel, while smaller, showed modest growth, representing 5% of total sales over the trailing 12-month period. The diversity of our end market continues to be a foundational strength of the Alliant model. This broad market reach, combined with our global customer base, helps mitigate volatility in any single area and enables us to allocate resources where we see the greatest return. As shown on Slide 7, gross margin was 32.2%, down just 10 basis points compared with the same period last year, despite lower year-over-year volume. Sequentially, gross margin expanded 70 basis points and was driven by higher volume, better mix, and continued implementation of our lean toolkit across the organization. Importantly, this marks the third consecutive quarter of gross margin expansion, up a total of 230 basis points since our low point in Q2, 2024. Moving to Slide 8, on a year-over-year basis, operating income was down due to lower volume and restructuring charges of $1.5 million versus minimal charges last year. In fact, when looking at operating expenses as a percentage of sales, restructuring and business realignment costs from the recent quarter contributed 90 basis points to the total 160 basis point increase. The remaining impact was largely reduced operating leverage on lower sales volume. Sequentially though, we saw a 60 basis point improvement in the operating cost ratio as we benefited from operating leverage, cost discipline, and the impact of our Simplify to Accelerate NOW program. As a result, operating income for the quarter was $8.8 million, with operating margin at 6.6%, up 130 basis points from Q4. Slide 9 highlights our bottom-line results, showing continued sequential improvements. I do want to call out that while our debt declined, our interest expense increased approximately $247,000 in the quarter. This was primarily driven by higher interest rates. The biggest driver was the expiration of two favorable interest rate swaps in December. They were replaced with a new swap at a higher rate, still competitive for the current market, but not as low as before. We also saw an increase compared to the prior year first quarter in the rates we were paying under our credit agreement related to the amendment made last fall. On a positive note, the benchmark interest rate we are tied to, SOFR, came down year over year, which helped offset some of the increase. As for our results, net income was $3.6 million or $0.21 per diluted share, compared with $3 million or $0.18 per diluted share in the prior period. Adjusted net income rose to $7.6 million, or $0.46 per share, up from $0.31 in Q4. Adjusted EBITDA was $17.5 million or 13.2% of revenue, up 160 basis points sequentially. These gains reflect our improving mix and the structural efficiencies we have been driving. Turning to cash generation and our balance sheet on Slides 10 and 11, operating cash flow was $13.9 million, up 52% from last year's first quarter, and up 12% over the sequential fourth quarter due to improved working capital. We ended the first quarter with $47.8 million in cash, an increase of 32% since year-end 2024. As a result, our net debt decreased by $13.6 million, bringing it to $174.4 million. Our leverage ratio, which we calculate as net debt divided by trailing 12-month adjusted EBITDA, improved to 2.91x. This was down from 3.01x at the end of December. Our bank-defined leverage ratio, which excludes certain items like foreign cash, came in at 3.56x at quarter end, and we will remain in full compliance with our debt covenants. These results are aligned with the three core financial priorities we have outlined for 2025. First, inventory management remains a top priority. We continue to drive improvements as our inventory in turn improves sequentially from 2.7 at the end of 2024 to 3.1 at March 2025, by reducing inventory levels through targeted planning, better alignment with customer demand, and focused execution in our supply chain. These efforts resulted in freeing up cash and improving cycle efficiency while still ensuring product availability for customers. Number two, cost discipline remains embedded in our operations. Through the Simplify to Accelerate NOW initiative and broader lean manufacturing efforts, we continue to identify and remove inefficiencies across the enterprise. These actions are continuing not just to improve profitability but to better cash conversion as well, whether through lower overhead, streamlined operations, or smarter procurement. Lastly, strengthening our balance sheet by reducing debt is a critical initiative of our financial strategy. The $13.6 million sequential reduction in net debt reflects higher operating cash flow and prudent capital allocation. As we progress through 2025, we expect to continue reducing debt, creating more flexibility for reinvestment and strategic execution. Capital expenditures were $1.1 million for the quarter, and we still anticipate capital spend of $10 million to $12 million for the full year 2025. With that, if you would advance to Slide 12, I will now turn the call back over to Dick.